LifeMD, Inc. (LFMD)

Market Cap	248.47M
Revenue (ttm)	245.56M
Net Income (ttm)	-9.03M
Shares Out	47.42M
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,660,602
Open	5.20
Previous Close	5.26
Day's Range	4.93 - 5.30
52-Week Range	4.13 - 15.84
Beta	1.33
Analysts	Buy
Price Target	12.50 (+138.55%)
Earnings Date	Nov 17, 2025

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications,...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1994
• Employees: 307
• Stock Exchange: NASDAQ
• Ticker Symbol: LFMD
• Website: https://lifemd.com

Financial Performance

In 2024, LifeMD's revenue was $212.45 million, an increase of 39.27% compared to the previous year's $152.55 million. Losses were -$21.99 million, -7.23% less than in 2023.

Analyst Summary

According to 6 analysts, the average rating for LFMD stock is "Buy." The 12-month stock price target is $12.5, which is an increase of 138.55% from the latest price.

Price Target

$12.5

(138.55% upside)

Analyst Consensus: Buy